Search Results 1391-1400 of 17812 for Substance+dependence

  1. Hematology - Clinical trials

    ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step-up dose optimization ...

  2. Clinical trials - Oncology (Medical)

    A Study to Test the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) with One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary ...

  3. Psychiatry and Psychology - Doctors - Mayo Clinic

    Drug addiction, Alcohol use disorder. Pagination Doctor search. PrevPrevious Page · Go to page 99 · Go to page 1010 · Go to page 1111 · Go to page 1212 · Go to ...

  4. Psychiatry and Psychology - Doctors - Mayo Clinic

    Drug addiction, Alcohol use disorder. Sondra Schultz, M.D.. Phoenix, AZ. Matt E. Schumann, Ph.D., L.P. ...

  5. Medical Research & Education - Mayo Clinic News Network

    ... drug-resistant. Featured News. New study in Brain Communications finds personalized deep brain stimulation shows promise for drug-resistant epilepsy. Alison ...

  6. Deep brain stimulation - Doctors & Departments - Mayo Clinic

    Deep brain stimulation in drug addiction treatment: Research progress and perspective. Frontiers in Psychiatry. 2022; doi:10.3389/fpsyt.2022.858638. Medical ...

  7. Medical Research & Education - Mayo Clinic News Network

    Latest stories. Researchers discover new molecular drug targets for progressive neurological disorder featured image. Discovery Science. Researchers discover ...

  8. Publications - Isa J. Houwink, M.D., Ph.D. - Mayo Clinic

    Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between TPMT/NUDT15 and thiopurines European Journal of Human Genetics. 2025 ...

  9. Medical Research & Education - Mayo Clinic News Network

    New study in Brain Communications finds personalized deep brain stimulation shows promise for drug-resistant · Hidden mutation leads to groundbreaking genetic ...

  10. A Study of Belantamab Mafodotin (GSK2857916) in Multiple Myeloma Participants With Normal and Impaired Renal Function - Mayo Clinic

    Belantamab mafodotin (GSK2857916) is an antibody-drug ... dependency, during the intervention period and ... Prior treatment with a monoclonal antibody within 30 ...